Motif ID: Junb_Jund
Z-value: 1.471
Transcription factors associated with Junb_Jund:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Junb | ENSMUSG00000052837.5 | Junb |
Jund | ENSMUSG00000071076.5 | Jund |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Junb | mm10_v2_chr8_-_84978709_84978748 | 0.49 | 1.5e-04 | Click! |
Jund | mm10_v2_chr8_+_70697739_70697739 | -0.23 | 9.7e-02 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 13.2 | GO:0003345 | proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
2.5 | 30.0 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
2.5 | 7.5 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
2.4 | 7.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
2.3 | 6.9 | GO:0030070 | insulin processing(GO:0030070) |
2.2 | 6.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) calcium-independent cell-matrix adhesion(GO:0007161) transforming growth factor-beta secretion(GO:0038044) |
2.1 | 18.6 | GO:0060373 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
2.1 | 6.2 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
1.9 | 17.2 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
1.8 | 9.0 | GO:0051012 | microtubule sliding(GO:0051012) |
1.8 | 8.8 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
1.7 | 7.0 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
1.7 | 12.0 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
1.6 | 4.9 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
1.5 | 13.9 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
1.5 | 7.6 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
1.5 | 4.4 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
1.4 | 6.8 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
1.3 | 1.3 | GO:0060067 | cervix development(GO:0060067) |
1.3 | 6.3 | GO:2000551 | regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
1.2 | 3.7 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
1.2 | 8.4 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
1.1 | 5.6 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
1.1 | 2.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
1.1 | 4.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.1 | 3.2 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
1.0 | 4.1 | GO:0090467 | regulation of amino acid import(GO:0010958) L-arginine import(GO:0043091) arginine import(GO:0090467) |
1.0 | 4.0 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
1.0 | 2.9 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
1.0 | 3.9 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.9 | 6.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.9 | 2.7 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.9 | 3.5 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
0.9 | 7.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.9 | 15.7 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.8 | 16.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.8 | 9.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.8 | 5.0 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.8 | 2.5 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) negative regulation of interleukin-10 secretion(GO:2001180) |
0.8 | 6.5 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.8 | 1.6 | GO:0035973 | aggrephagy(GO:0035973) |
0.8 | 7.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.8 | 2.3 | GO:0019085 | early viral transcription(GO:0019085) |
0.8 | 2.3 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.8 | 9.9 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.8 | 4.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.7 | 2.2 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.7 | 4.4 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.7 | 3.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.7 | 2.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.7 | 8.6 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.7 | 2.1 | GO:0002182 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.7 | 4.8 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.7 | 3.3 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.7 | 7.8 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.6 | 1.9 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
0.6 | 13.4 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.6 | 5.6 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.6 | 5.6 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.6 | 1.8 | GO:0031038 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.6 | 1.8 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.6 | 4.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.6 | 2.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.6 | 1.8 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) actin filament branching(GO:0090135) |
0.6 | 1.7 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.6 | 2.3 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.6 | 2.2 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.6 | 2.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.6 | 2.8 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.6 | 1.7 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.6 | 1.7 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.5 | 3.3 | GO:0098964 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
0.5 | 9.3 | GO:0001553 | luteinization(GO:0001553) |
0.5 | 0.5 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.5 | 11.2 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.5 | 1.0 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
0.5 | 1.6 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.5 | 1.6 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.5 | 51.2 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.5 | 1.5 | GO:0019389 | urate transport(GO:0015747) glucuronoside metabolic process(GO:0019389) negative regulation of intestinal absorption(GO:1904479) |
0.5 | 1.4 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.5 | 2.3 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.4 | 1.3 | GO:1903538 | meiotic sister chromatid cohesion, centromeric(GO:0051754) meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.4 | 3.0 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.4 | 2.6 | GO:0060702 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
0.4 | 6.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.4 | 2.0 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.4 | 4.4 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.4 | 1.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.4 | 2.0 | GO:0060690 | epithelial cell differentiation involved in salivary gland development(GO:0060690) |
0.4 | 4.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.4 | 15.5 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.4 | 0.4 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
0.4 | 1.9 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.4 | 1.9 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.4 | 1.5 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.4 | 1.1 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
0.4 | 9.4 | GO:0071625 | vocalization behavior(GO:0071625) |
0.4 | 1.9 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.4 | 1.1 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.4 | 1.1 | GO:0061744 | motor behavior(GO:0061744) |
0.4 | 1.1 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.4 | 1.8 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.4 | 1.1 | GO:0035844 | positive regulation of polarized epithelial cell differentiation(GO:0030862) cloaca development(GO:0035844) |
0.4 | 1.1 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.4 | 29.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.4 | 3.2 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.3 | 1.4 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.3 | 1.7 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.3 | 1.4 | GO:2000481 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
0.3 | 0.7 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.3 | 1.0 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.3 | 0.7 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
0.3 | 4.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.3 | 2.3 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.3 | 2.9 | GO:0050957 | equilibrioception(GO:0050957) |
0.3 | 4.9 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.3 | 1.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 0.6 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.3 | 1.6 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.3 | 2.9 | GO:0009644 | response to high light intensity(GO:0009644) |
0.3 | 1.6 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.3 | 2.6 | GO:0021830 | substrate-independent telencephalic tangential migration(GO:0021826) interneuron migration from the subpallium to the cortex(GO:0021830) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
0.3 | 1.0 | GO:0021592 | fourth ventricle development(GO:0021592) actin filament bundle distribution(GO:0070650) |
0.3 | 3.8 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.3 | 1.6 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.3 | 2.5 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.3 | 4.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.3 | 2.8 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.3 | 3.3 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.3 | 2.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.3 | 6.9 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.3 | 6.8 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.3 | 1.8 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.3 | 1.1 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.3 | 3.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.3 | 3.4 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.3 | 1.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.3 | 2.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.3 | 3.1 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.3 | 3.4 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.3 | 1.4 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.3 | 0.8 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.3 | 1.3 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.3 | 1.3 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.3 | 0.8 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) |
0.2 | 1.7 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 0.7 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.2 | 11.0 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.2 | 2.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 1.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.2 | 0.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 4.0 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.2 | 1.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 4.3 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 0.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 0.7 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.2 | 1.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 5.8 | GO:0001706 | endoderm formation(GO:0001706) |
0.2 | 3.6 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.2 | 5.3 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.2 | 2.6 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 1.9 | GO:0046541 | saliva secretion(GO:0046541) |
0.2 | 0.4 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.2 | 1.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.2 | 3.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 0.6 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 0.4 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.2 | 2.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.2 | 2.2 | GO:0043084 | penile erection(GO:0043084) |
0.2 | 0.6 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.2 | 1.2 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 0.6 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.2 | 1.3 | GO:0051004 | plasma membrane to endosome transport(GO:0048227) regulation of lipoprotein lipase activity(GO:0051004) |
0.2 | 0.8 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.2 | 4.2 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.2 | 1.5 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.2 | 1.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.2 | 2.6 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 0.2 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.2 | 1.7 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 2.7 | GO:0003094 | glomerular filtration(GO:0003094) |
0.2 | 0.9 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.2 | 3.9 | GO:0002931 | response to ischemia(GO:0002931) |
0.2 | 1.2 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 2.1 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.2 | 0.5 | GO:2000850 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.2 | 0.4 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.2 | 1.4 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.2 | 1.4 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 2.9 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.2 | 3.0 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.2 | 0.3 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.2 | 1.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 1.2 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.2 | 1.1 | GO:0032782 | bile acid secretion(GO:0032782) positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.2 | 0.8 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 5.2 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.2 | 0.5 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.2 | 0.9 | GO:0099563 | modification of synaptic structure(GO:0099563) |
0.2 | 0.5 | GO:0043696 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.2 | 0.3 | GO:0090399 | replicative senescence(GO:0090399) |
0.1 | 0.9 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.1 | 4.8 | GO:0008542 | visual learning(GO:0008542) |
0.1 | 2.2 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.9 | GO:2001204 | neutrophil activation involved in immune response(GO:0002283) regulation of osteoclast development(GO:2001204) |
0.1 | 2.5 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 1.5 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 4.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 1.0 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 1.7 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.1 | 0.5 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 2.6 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 1.7 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.1 | 0.4 | GO:0090370 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) negative regulation of cholesterol efflux(GO:0090370) |
0.1 | 1.0 | GO:0080184 | response to stilbenoid(GO:0035634) response to phenylpropanoid(GO:0080184) |
0.1 | 0.5 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 1.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 1.0 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 0.4 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.7 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.7 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 0.8 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.1 | GO:0021612 | facial nerve structural organization(GO:0021612) |
0.1 | 7.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 1.8 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.9 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 1.1 | GO:0051231 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) mitotic spindle midzone assembly(GO:0051256) |
0.1 | 0.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.4 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 | 1.1 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.1 | 0.8 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.1 | 0.3 | GO:0051030 | snRNA transport(GO:0051030) |
0.1 | 1.4 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.1 | 0.6 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 2.7 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.1 | 0.6 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 | 5.9 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 0.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 1.1 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 5.6 | GO:0007613 | memory(GO:0007613) |
0.1 | 0.2 | GO:0014060 | regulation of epinephrine secretion(GO:0014060) |
0.1 | 0.4 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.8 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.1 | 3.3 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.1 | 0.5 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 2.4 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 1.3 | GO:0035036 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
0.1 | 0.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 2.4 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.1 | 0.2 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.1 | 1.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.5 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) growth plate cartilage chondrocyte proliferation(GO:0003419) negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.1 | 0.4 | GO:0007632 | visual behavior(GO:0007632) |
0.1 | 3.1 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.9 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 6.1 | GO:0015758 | glucose transport(GO:0015758) |
0.1 | 1.8 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 10.1 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.1 | 4.1 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 2.5 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.5 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.1 | 0.5 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.8 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.1 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) endoplasmic reticulum mannose trimming(GO:1904380) |
0.1 | 0.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) embryonic skeletal joint development(GO:0072498) |
0.1 | 1.1 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.2 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.1 | 3.8 | GO:0021549 | cerebellum development(GO:0021549) |
0.1 | 0.7 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.1 | 4.7 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 1.3 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.1 | 0.4 | GO:0002051 | mesodermal cell fate commitment(GO:0001710) osteoblast fate commitment(GO:0002051) |
0.0 | 0.6 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.4 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.0 | GO:0002374 | cytokine secretion involved in immune response(GO:0002374) regulation of cytokine secretion involved in immune response(GO:0002739) positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.0 | 0.2 | GO:0034242 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.0 | 0.5 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.0 | 3.2 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.0 | 1.9 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 5.2 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.4 | GO:0086004 | regulation of cardiac muscle cell contraction(GO:0086004) |
0.0 | 0.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 25.2 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.0 | 0.8 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.0 | 2.9 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.4 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.0 | 0.7 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.4 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.0 | 0.5 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 1.3 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.0 | 0.3 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.2 | GO:0060449 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) bud elongation involved in lung branching(GO:0060449) |
0.0 | 0.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 1.0 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 1.0 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.4 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 1.3 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 1.0 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.0 | 1.3 | GO:0048675 | axon extension(GO:0048675) |
0.0 | 4.0 | GO:0006869 | lipid transport(GO:0006869) |
0.0 | 0.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.7 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.5 | GO:0042100 | B cell proliferation(GO:0042100) |
0.0 | 0.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.1 | GO:0001842 | neural fold formation(GO:0001842) |
0.0 | 0.4 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.6 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 1.1 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.0 | 0.2 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.0 | 0.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.2 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.2 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
0.0 | 0.2 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.4 | GO:0006611 | protein export from nucleus(GO:0006611) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 6.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.9 | 1.9 | GO:0097447 | dendritic tree(GO:0097447) |
1.7 | 8.4 | GO:0032437 | cuticular plate(GO:0032437) |
1.7 | 24.8 | GO:0044754 | autolysosome(GO:0044754) |
1.6 | 4.9 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.4 | 5.6 | GO:0031673 | H zone(GO:0031673) |
1.2 | 7.5 | GO:0000235 | astral microtubule(GO:0000235) |
1.2 | 18.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.2 | 3.6 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
1.1 | 3.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.0 | 6.3 | GO:0045179 | apical cortex(GO:0045179) |
0.9 | 24.1 | GO:0031430 | M band(GO:0031430) |
0.8 | 5.8 | GO:0000322 | storage vacuole(GO:0000322) |
0.8 | 2.3 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.7 | 2.2 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.7 | 2.7 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.6 | 2.5 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.6 | 4.0 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.5 | 2.7 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.5 | 3.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.5 | 4.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.5 | 18.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.5 | 2.8 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.5 | 18.4 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.4 | 2.9 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.4 | 7.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.4 | 5.6 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.4 | 4.4 | GO:0042581 | specific granule(GO:0042581) |
0.4 | 7.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.4 | 4.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.4 | 3.2 | GO:0045252 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
0.3 | 2.4 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.3 | 1.4 | GO:1990415 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
0.3 | 1.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.3 | 5.3 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 4.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.3 | 5.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 2.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.3 | 15.5 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 3.0 | GO:0001739 | sex chromatin(GO:0001739) |
0.3 | 0.6 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 2.1 | GO:0070187 | telosome(GO:0070187) |
0.3 | 106.6 | GO:0014069 | postsynaptic density(GO:0014069) |
0.3 | 3.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.3 | 3.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.3 | 0.8 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.3 | 1.1 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.3 | 5.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 1.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 1.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 2.3 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 2.8 | GO:0000974 | Prp19 complex(GO:0000974) |
0.2 | 2.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 1.3 | GO:0070847 | core mediator complex(GO:0070847) |
0.2 | 1.7 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 5.9 | GO:0060076 | excitatory synapse(GO:0060076) |
0.2 | 4.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 13.1 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 0.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 1.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 5.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.2 | 3.6 | GO:0030118 | clathrin coat(GO:0030118) |
0.2 | 2.1 | GO:0043235 | receptor complex(GO:0043235) |
0.2 | 1.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 0.2 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
0.2 | 1.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 1.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 2.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 3.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 9.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 3.3 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 1.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 1.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 7.1 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 6.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 1.5 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 1.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 1.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 2.0 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 0.7 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 18.1 | GO:0030141 | secretory granule(GO:0030141) |
0.1 | 1.4 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 1.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 3.3 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.3 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 1.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 6.6 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 14.8 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 1.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 6.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 5.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 1.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 1.4 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 5.6 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 0.8 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 2.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 3.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 7.6 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 2.1 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 2.5 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 1.9 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 11.9 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 1.1 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 1.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 7.3 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 3.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 3.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.5 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 1.8 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 2.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.4 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.8 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.6 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.5 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 1.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 3.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 1.9 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 1.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 1.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 2.0 | GO:0043197 | dendritic spine(GO:0043197) |
0.0 | 47.7 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 3.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 2.7 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.5 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 0.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.8 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.4 | GO:0044433 | cytoplasmic vesicle part(GO:0044433) |
0.0 | 4.1 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 2.3 | GO:0030425 | dendrite(GO:0030425) |
0.0 | 0.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 1.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 1.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 1.1 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 1.7 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.0 | 3.5 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 3.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 2.4 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 1.6 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.5 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.6 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 26.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
2.7 | 18.6 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
2.4 | 7.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
1.9 | 5.8 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
1.6 | 6.4 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.4 | 13.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.3 | 5.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
1.3 | 3.9 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
1.2 | 3.7 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
1.2 | 4.9 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
1.2 | 4.8 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
1.2 | 3.5 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
1.1 | 3.4 | GO:0097677 | STAT family protein binding(GO:0097677) |
1.1 | 4.5 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.1 | 9.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.1 | 4.4 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
1.1 | 3.3 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
1.1 | 6.5 | GO:0045340 | mercury ion binding(GO:0045340) |
1.1 | 3.2 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
1.0 | 3.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
1.0 | 2.9 | GO:1990955 | G-rich single-stranded DNA binding(GO:1990955) |
0.9 | 6.6 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.9 | 3.6 | GO:0035473 | lipase binding(GO:0035473) |
0.9 | 11.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.9 | 2.6 | GO:0033699 | DNA 5'-adenosine monophosphate hydrolase activity(GO:0033699) |
0.9 | 6.9 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.8 | 13.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.8 | 8.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.7 | 2.2 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.7 | 7.8 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.7 | 4.9 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.7 | 4.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.7 | 5.3 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.6 | 1.9 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.6 | 3.2 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.6 | 1.3 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.6 | 4.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.6 | 9.0 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.6 | 4.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.6 | 13.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.6 | 1.7 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.6 | 1.7 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.6 | 6.8 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.6 | 5.0 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.5 | 18.0 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.5 | 11.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.5 | 10.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.5 | 8.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.5 | 9.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.5 | 2.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 1.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.4 | 2.7 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.4 | 2.2 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.4 | 1.8 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 2.6 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.4 | 1.7 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.4 | 2.5 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.4 | 9.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.4 | 1.2 | GO:0000992 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.4 | 10.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.4 | 2.0 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.4 | 3.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.4 | 1.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.4 | 2.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.4 | 1.2 | GO:0004458 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
0.4 | 3.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.4 | 1.1 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.4 | 1.8 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.3 | 8.4 | GO:0030506 | ankyrin binding(GO:0030506) |
0.3 | 1.7 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.3 | 1.0 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.3 | 1.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 2.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 20.8 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.3 | 2.2 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.3 | 5.0 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 5.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.3 | 1.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.3 | 1.5 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.3 | 1.4 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.3 | 3.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 2.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.3 | 5.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 2.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.3 | 3.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 7.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 1.4 | GO:0004043 | L-aminoadipate-semialdehyde dehydrogenase activity(GO:0004043) |
0.2 | 17.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.2 | 2.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 0.7 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.2 | 1.5 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.2 | 1.9 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 1.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 4.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 2.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 0.8 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.2 | 2.5 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 5.9 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.2 | 1.3 | GO:0032564 | dATP binding(GO:0032564) |
0.2 | 1.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 2.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 3.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 7.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 58.8 | GO:0015631 | tubulin binding(GO:0015631) |
0.2 | 1.5 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 11.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.2 | 0.7 | GO:0070573 | tripeptidyl-peptidase activity(GO:0008240) metallodipeptidase activity(GO:0070573) |
0.2 | 0.8 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.2 | 5.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 2.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 3.0 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 0.2 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.2 | 5.4 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 2.9 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 1.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 42.3 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 0.6 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 9.4 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 14.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 3.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.8 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.1 | 1.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 4.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 2.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 1.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.2 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.1 | 1.8 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 2.8 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 2.8 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.1 | 1.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 1.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.6 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 2.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 2.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 1.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 4.7 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 2.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 7.7 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 6.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 12.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 6.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 8.7 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.4 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 4.0 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 2.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 2.1 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 1.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 4.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.2 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.1 | 0.9 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 30.2 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.4 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.1 | 4.7 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.1 | 2.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.9 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 3.0 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 1.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 3.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.4 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.1 | 1.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.2 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.1 | 0.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 1.9 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.1 | 1.5 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 1.2 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.0 | 0.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.8 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 2.4 | GO:0019955 | cytokine binding(GO:0019955) |
0.0 | 0.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.3 | GO:0098505 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 1.1 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 13.9 | GO:0008289 | lipid binding(GO:0008289) |
0.0 | 0.7 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.0 | 2.7 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.0 | 0.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.7 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 1.7 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.6 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.9 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.3 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.4 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.8 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.6 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.5 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.2 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 4.2 | PID_ATF2_PATHWAY | ATF-2 transcription factor network |
0.4 | 20.0 | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | Genes related to regulation of the actin cytoskeleton |
0.4 | 10.9 | PID_INTEGRIN_A9B1_PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 9.7 | PID_INSULIN_GLUCOSE_PATHWAY | Insulin-mediated glucose transport |
0.3 | 1.1 | ST_IL_13_PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 10.0 | PID_LIS1_PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.3 | 5.1 | ST_G_ALPHA_S_PATHWAY | G alpha s Pathway |
0.2 | 16.4 | PID_ERBB1_INTERNALIZATION_PATHWAY | Internalization of ErbB1 |
0.2 | 5.0 | PID_S1P_META_PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 6.9 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 10.4 | SIG_CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 2.8 | PID_KIT_PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 1.6 | PID_CXCR4_PATHWAY | CXCR4-mediated signaling events |
0.2 | 5.1 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 3.1 | ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY | PI3K Pathway |
0.2 | 3.0 | PID_CIRCADIAN_PATHWAY | Circadian rhythm pathway |
0.2 | 5.3 | NABA_PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 3.0 | PID_NFKAPPAB_CANONICAL_PATHWAY | Canonical NF-kappaB pathway |
0.1 | 1.6 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
0.1 | 6.7 | PID_TAP63_PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 3.2 | ST_GA13_PATHWAY | G alpha 13 Pathway |
0.1 | 9.4 | PID_TGFBR_PATHWAY | TGF-beta receptor signaling |
0.1 | 1.0 | PID_TCR_CALCIUM_PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 3.9 | PID_PI3KCI_PATHWAY | Class I PI3K signaling events |
0.1 | 2.6 | PID_DNA_PK_PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 5.4 | PID_ARF6_TRAFFICKING_PATHWAY | Arf6 trafficking events |
0.1 | 7.6 | PID_RAC1_REG_PATHWAY | Regulation of RAC1 activity |
0.1 | 0.7 | SA_MMP_CYTOKINE_CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 1.7 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 2.6 | PID_ARF_3PATHWAY | Arf1 pathway |
0.1 | 5.9 | PID_LKB1_PATHWAY | LKB1 signaling events |
0.1 | 0.5 | PID_IL5_PATHWAY | IL5-mediated signaling events |
0.1 | 1.3 | PID_IL8_CXCR2_PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 1.2 | PID_ERB_GENOMIC_PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.9 | PID_ER_NONGENOMIC_PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 2.6 | PID_IL4_2PATHWAY | IL4-mediated signaling events |
0.1 | 2.0 | PID_INTEGRIN_A4B1_PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 1.7 | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 1.5 | PID_BETA_CATENIN_DEG_PATHWAY | Degradation of beta catenin |
0.1 | 1.6 | PID_HIV_NEF_PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 0.4 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 1.0 | PID_RHOA_PATHWAY | RhoA signaling pathway |
0.1 | 1.9 | PID_INTEGRIN1_PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 1.9 | PID_NFAT_3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 1.1 | PID_MAPK_TRK_PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.3 | PID_SHP2_PATHWAY | SHP2 signaling |
0.1 | 0.4 | PID_ALK2_PATHWAY | ALK2 signaling events |
0.0 | 0.7 | PID_TRKR_PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 1.6 | PID_P75_NTR_PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.4 | PID_EPHA_FWDPATHWAY | EPHA forward signaling |
0.0 | 0.3 | PID_NECTIN_PATHWAY | Nectin adhesion pathway |
0.0 | 1.1 | WNT_SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.6 | PID_NCADHERIN_PATHWAY | N-cadherin signaling events |
0.0 | 0.4 | PID_AR_TF_PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.2 | PID_P38_ALPHA_BETA_PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.1 | PID_INTEGRIN2_PATHWAY | Beta2 integrin cell surface interactions |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 26.0 | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.0 | 36.0 | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.8 | 5.9 | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.5 | 4.8 | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.5 | 7.6 | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.4 | 5.3 | REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.4 | 5.7 | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.4 | 10.5 | REACTOME_CGMP_EFFECTS | Genes involved in cGMP effects |
0.4 | 0.7 | REACTOME_ADP_SIGNALLING_THROUGH_P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.3 | 5.6 | REACTOME_GABA_A_RECEPTOR_ACTIVATION | Genes involved in GABA A receptor activation |
0.3 | 0.7 | REACTOME_SHC_MEDIATED_SIGNALLING | Genes involved in SHC-mediated signalling |
0.3 | 5.4 | REACTOME_ACTIVATION_OF_RAC | Genes involved in Activation of Rac |
0.3 | 7.1 | REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.3 | 13.4 | REACTOME_DARPP_32_EVENTS | Genes involved in DARPP-32 events |
0.3 | 11.2 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.3 | 2.4 | REACTOME_GAP_JUNCTION_DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 6.1 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 3.2 | REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 5.3 | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 1.3 | REACTOME_ERKS_ARE_INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 2.7 | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 1.8 | REACTOME_CD28_DEPENDENT_VAV1_PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 4.5 | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.2 | 3.9 | REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 6.9 | REACTOME_G_PROTEIN_ACTIVATION | Genes involved in G-protein activation |
0.2 | 2.0 | REACTOME_PLATELET_SENSITIZATION_BY_LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 5.4 | REACTOME_IL_RECEPTOR_SHC_SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 3.6 | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 2.6 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 6.2 | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.8 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 3.1 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.2 | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | Genes involved in Transport of organic anions |
0.1 | 1.5 | REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 10.7 | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 3.0 | REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.4 | REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 1.4 | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 1.6 | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 2.2 | REACTOME_INSULIN_RECEPTOR_RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.9 | REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 3.5 | REACTOME_GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 0.9 | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 3.4 | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.6 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 0.8 | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN1_SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 2.4 | REACTOME_SIGNALING_BY_HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.3 | REACTOME_NOD1_2_SIGNALING_PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 8.3 | REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 2.6 | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.7 | REACTOME_BASE_FREE_SUGAR_PHOSPHATE_REMOVAL_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.6 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 2.3 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 4.4 | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_ | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.1 | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.8 | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 2.1 | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.8 | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 1.2 | REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.7 | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 1.6 | REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 1.6 | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.4 | REACTOME_GAP_JUNCTION_TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 2.2 | REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.4 | REACTOME_IL_3_5_AND_GM_CSF_SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 0.8 | REACTOME_METABOLISM_OF_PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 3.4 | REACTOME_SIGNALING_BY_RHO_GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.4 | REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.4 | REACTOME_CIRCADIAN_CLOCK | Genes involved in Circadian Clock |
0.0 | 1.4 | REACTOME_NCAM1_INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.8 | REACTOME_DEADENYLATION_OF_MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 1.3 | REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.7 | REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.3 | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.3 | REACTOME_EGFR_DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.6 | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.4 | REACTOME_SIGNALING_BY_BMP | Genes involved in Signaling by BMP |
0.0 | 0.1 | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.6 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |